Highlights of ASH® Goes Virtual, Trainee Awards for Underrepresented Minorities, and more

Highlights of ASH® Goes Virtual

Each year, the American Society of Hematology’s (ASH’s) Highlights of ASH® meeting series offers a synopsis of the top hematology research presented at the latest ASH annual meeting, as well as a chance to discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field.

The regional 2021 Highlights of ASH meetings originally scheduled to take place in North America (January), the Mediterranean (February), Asia-Pacific (March), and Latin America (April) will be offered as a collective virtual experience in March 2021.

Detailed information will be available in the coming weeks at hematology.org/highlights.


Trainee Awards for Underrepresented Minorities

ASH has provided more than $12 million in career development and training awards to early- and mid-career hematologists. Understanding the impact that the global COVID-19 pandemic response has had on the economy and on medical research, the Society is continuing to provide support and much-needed education and training to ASH members around the world, including maintaining funding for all 2020-2021 awards.

Through the ASH Minority Recruitment Initiative (MRI), the Society is working to increase the participation of underrepresented minority trainees in hematology-related fields and to increase the number of minority hematologists with academic and research appointments.

The following MRI awards have upcoming deadlines of January 15, 2021:

The Minority Hematology Graduate Award provides support for underrepresented minority doctoral students in their first, second, or third year of graduate school to conduct hematology-focused research.

The Minority Hematology Fellow Award provides salary support and funds to support hematology-focused research projects to underrepresented minority fellows in their first or second year of fellowship.

The Minority Medical Student Award Program offers mentored introductory biomedical research experience to underrepresented minority medical students.

The Minority Resident Hematology Award Program provides support for underrepresented minority resident physicians in an internal medicine, pathology, or pediatric residency program to conduct hematology-focused research.

Learn more about ASH’s Awards and Diversity Programs and apply today at hematology.org/awards.


ASH-ASTCT COVID-19 and Vaccines FAQs

ASH and the American Society for Transplantation and Cellular Therapy (ASTCT) have developed a set of frequently asked questions (FAQs) to guide hematologists on COVID-19 and vaccines for the immunocompromised as part of the regularly updated ASH COVID-19 resources available on the ASH website. The questions include:

  • What SARS-CoV-2 vaccines are approved for use in immunocompromised patients?
  • What are mechanisms of action for the leading candidate SARS-CoV-2 vaccines?
  • Why might some hematology patients not respond to vaccines?
  • What is known about the safety and efficacy of protein-based or killed (inactivated virus) vaccines in immunocompromised patients?
  • What is known about the safety and efficacy of attenuated live vaccines in immunocompromised patients?
  • Although there are no data for mRNA/DNA and using other viruses to deliver vaccines, what are the theoretical considerations in immunocompromised patients?
  • If immunocompromised patients were not included in the vaccine trials and are less likely to respond to a SARS-CoV-2 vaccine, should they still receive it? What is the timing in relation to chemotherapy, transplant, antibody therapy, splenectomy, etc.
  • Should higher vaccine doses or multiple vaccine types be used?

Find responses to these FAQs and other ASH COVID-19 resources at hematology.org/COVID-19.


The 2020 ASH Foundation Run/Walk is Still On!

This year’s ASH Foundation Run/Walk has transitioned to a virtual format that will allow annual meeting attendees the most flexibility to participate. Registrants should plan to run or walk a 3K or 5K route wherever is most convenient for them, during the two-week period of November 27 through December 11.

With the free RaceJoy app (available on iOS and Android), runners and walkers can track progress, submit finish times, and upload photos. Finish times can also be uploaded to the ASH Foundation Run/Walk website, where participants can monitor the live leaderboard.
All of the proceeds from registration and additional donations will benefit the ASH Research Restart Award, which aims to reduce the impact that the global COVID-19 pandemic response has had on the progression of research and careers for early-career investigators in hematology.

Don’t forget to share your progress and cheer teammates on with the hashtags #IWalkForASH or #IRunForASH!

Learn more and register by December 10 at hematology.org/foundation/run-walk.


APPLY NOW! 2021 ASH Clinical Research Training Institute

The ASH Clinical Research Training Institute (CRTI) is a unique, year-long education and mentoring program for hematology fellows and junior faculty at academic medical centers. CRTI offers a broad education on clinical research methods, research collaborations, and statistical analysis, as well as advice for managing the demands of family and career.

CRTI consists of four components: A week-long workshop in August in La Jolla, California, which focuses on the foundation, methodologies, and application of patient-oriented clinical research; a follow-up meeting at the ASH annual meeting in December; a one-day class in May at ASH Headquarters in Washington, DC; and networking and mentorship through distance learning, which takes place between the in-person meetings.

All meeting locations are tentative, as ASH understands that that the COVID-19 pandemic makes it challenging to plan for travel in the near future. If travel is not feasible, the meetings will be held virtually. ASH is closely monitoring the situation and will notify 2021 applicants if any changes are made to the program.

Learn more about CRTI and submit your letter of intent by January 8 at hematology.org/crti.